Cornell University
Zwitterionic Hydrogel Delivery System for In Vivo Extracellular Vesicle Therapy of Breast Cancer
Abstract
dc:description.abstractZwitterionic polymers and hydrogels have gained significant interest in biomedical applications due to their excellent biocompatibility and ultra-low biofouling properties. Despite this, their feasibility in cell encapsulation and in vivo cell therapy has been minimally explored. In this study, we synthesized an injectable poly (carboxybetaine acrylamide) (pCBAA) zwitterionic hydrogel tailored for cell encapsulation. Utilizing this hydrogel, we investigated its potential for in vivo extracellular vesicle (EV) therapy of breast cancer. Here, we demonstrate that low cytotoxicity, low mechanical properties, and thermal crosslinking make this injectable zwitterionic hydrogel suitable for cell encapsulation. The injectable zwitterionic hydrogel keeps encapsulated donor cells at low metabolism with reduced EV production function under the in vitro environment. In vivo hydrogel implantation indicates pCBAA hydrogel induces limited foreign body response and immune response. Moreover, the zwitterionic also promotes angiogenesis in surrounding tissue with pro-healing functions. These findings suggest the potential of zwitterionic hydrogels for cell encapsulation and cell therapy.
Degree
thesis:*- Name thesis:degree_name
- M.S., Materials Science and Engineering
- Level thesis:degree_level
- Master of Science
- Discipline thesis:degree_discipline
- Materials Science and Engineering
- Grantor
- Cornell University
- Year dc:date.issued
- 2024
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Huang, Sizhe
- Chair dc:contributor.chair
-
- Jiang, Shaoyi
- Committee member dc:contributor.committeemember
-
- Silberstein, Meredith
Subjects
dc:subject × 4Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Dc Identifier Bibid
- 16611847
- Dc Identifier Other
-
ProQuest Submission ID: 12269
ProQuest Publication ID: 31489592